Aptevo Therapeutics Inc. (APVO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aptevo Therapeutics Inc.

    NASDAQ: APVO · Real-Time Price · USD
    1.61
    -0.02 (-1.23%)
    At close: Sep 05, 2025, 3:59 PM
    1.61
    0.16%
    Pre-market: Sep 08, 2025, 08:22 AM EDT

    Aptevo Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 3.11M 12.29M
    Cost of Revenue
    		 352K 17.11M 17.88M 18.99M
    Gross Profit
    		 -352K -567K -14.77M -6.7M
    Operating Income
    		 -24.6M -28.88M -28.64M -21.4M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -24.13M -18.65M 7.01M -29.41M
    Net Income
    		 -24.13M -17.41M 8.03M -27.31M
    Selling & General & Admin
    		 10.22M 11.77M 13.87M 14.7M
    Research & Development
    		 14.38M 17.11M 17.88M 18.99M
    Other Expenses
    		 -352K -17.11M -1.53M -8.01M
    Operating Expenses
    		 24.25M 28.31M 31.75M 33.69M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 24.6M 28.88M 31.75M 33.69M
    Income Tax Expense
    		 n/a n/a n/a -2.1M
    Shares Outstanding (Basic)
    		 13.81K 375.76 156.64 143.98
    Shares Outstanding (Diluted)
    		 13.81K 375.76 156.72 143.98
    EPS (Basic)
    		 -1.75K -46.34K 51.24K -197.65K
    EPS (Diluted)
    		 -1.75K -46.34K 51.22K -197.65K
    EBITDA
    		 -23.78M -28.31M -27.74M -20.26M
    EBIT
    		 -24.13M -28.88M -28.64M -21.4M
    Depreciation & Amortization
    		 352K 567K 901K 1.14M

    Add to Watchlist